ACG
GILD icon

Allen Capital Group’s Gilead Sciences GILD Stock Holding History

Allen Capital Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$316K Buy
2,504
+104
+4% +$13.7K 0.03% 242
2026
Q1 		$334K Buy
2,400
+112
+5% +$15.7K 0.03% 225
2025
Q4 		$281K Buy
2,288
+119
+5% +$14.5K 0.03% 235
2025
Q3 		$241K Buy
2,169
+184
+9% +$20.9K 0.02% 242
2025
Q2 		$220K Buy
+1,985
New +$211K 0.02% 252
2021
Q3 		– Sell
-3,007
Closed -$207K – 165
2021
Q2 		$207K Sell
3,007
-5,908
-66% -$394K 0.04% 147
2021
Q1 		$576K Buy
8,915
+1,378
+18% +$88.9K 0.13% 94
2020
Q4 		$439K Sell
7,537
-1,948
-21% -$118K 0.11% 100
2020
Q3 		$612K Buy
9,485
+1,051
+12% +$72.9K 0.15% 89
2020
Q2 		$649K Buy
+8,434
New +$646K 0.17% 81

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Allen Capital Group's GILD Position: Q2 2026 in Review

Allen Capital Group increased its Gilead Sciences (GILD) stake by 4.3% in Q2 2026, buying an estimated $13.7K and bringing the position to 2,504 shares worth $316K. The position accounts for 0.03% of the portfolio, ranked #242.

Allen Capital Group first reported a position in GILD in Q2 2020 and has held it in 10 quarters since. The position peaked at $649K in Q2 2020. 2,281 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Allen Capital Group held 2,504 shares of Gilead Sciences worth $316K as of Q2 2026.
  • Allen Capital Group bought 104 Gilead Sciences shares in Q2 2026, an estimated $13.7K.
  • Gilead Sciences made up 0.03% of Allen Capital Group's portfolio in Q2 2026, its #242 holding.
  • Allen Capital Group first reported a position in Gilead Sciences in Q2 2020 and has held it in 10 quarters since.
  • Allen Capital Group's Gilead Sciences position peaked at $649K in Q2 2020.
  • 2,281 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Allen Capital Group's 13F filing for Q2 2026, filed 27 Jul 2026.